The Department of Veterans Affairs is soliciting bids for fluorodeoxyglucose (F18-FDG) doses for PET/CT scans through a combined synopsis/solicitation notice, identified as solicitation number 36C25624Q1348. This request, formatted in accordance with federal acquisition regulations, aims to procure commercial items and is categorized under Product Service Code 6505. The requirement is unrestricted and adheres to the NAICS code 325412, which indicates a size standard of 1,300 employees. Proposals must be submitted by October 25, 2024, by 10:00 AM Central Time. The contract will be managed by the Network Contracting Office 16, located in Houston, Texas, with service delivery expected at the Overton Brooks VA Medical Center in Shreveport, Louisiana. This solicitation does not anticipate issuing a separate written solicitation and emphasizes the urgency for qualified vendors to respond.
The document is a combined synopsis/solicitation for a contract to provide radiopharmaceutical supplies, specifically Fluorodeoxyglucose F-18 (FDG), to the Overton Brooks VA Medical Center in Shreveport, LA. The solicitation, designated as 36C25624Q1348, outlines a firm-fixed price contract with a base year and four optional one-year extensions. A key requirement is that the contractor must deliver the specified quantities within established timeframes and dispose of any radioactive waste generated. The contractor is also responsible for maintaining necessary licenses and providing consultation services regarding radiopharmaceutical applications. Quotes are due by 10/25/2024, with all inquiries directed to the Contract Specialist. The document includes various federal acquisition clauses governing the contract, emphasizing compliance with regulatory standards. Overall, this solicitation aims to support the VA's nuclear medicine program and fulfill the healthcare needs of veterans while adhering to safety and regulatory guidelines.